Hantz Financial Services, Inc. Abbott Laboratories Transaction History

Hantz Financial Services, Inc.

$5.74 Billion
Q4 2024

A detailed history of Hantz Financial Services, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Hantz Financial Services, Inc. holds 284,986 shares of ABT stock, worth $39.2 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares

284,986

Previous 291,753 2.32%

Holding current value

$39.2 Million

Previous $33.3 Million 3.09%

% of portfolio

0.56%

Previous 0.59%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 23, 2025	SELL	$111.93 - $119.39 $757,430 - $807,912	-6,767 Reduced 2.32%	284,986 $32.2 Million
Q3 2024 Nov 13, 2024	SELL	$100.07 - $118.13 $710,196 - $838,368	-7,097 Reduced 2.37%	291,753 $33.3 Million
Q2 2024 Jul 30, 2024	BUY	$100.73 - $112.44 $30.1 Million - $33.6 Million	298,850 New	298,850 $31.1 Million
Q1 2024 Aug 06, 2024	BUY	$109.52 - $120.96 $2.12 Million - $2.34 Million	19,371 Added 7.85%	266,115 $30.2 Million
Q4 2023 Aug 06, 2024	SELL	$90.19 - $110.4 $1.4 Million - $1.71 Million	-15,509 Reduced 5.91%	246,744 $27.2 Million
Q3 2023 Aug 06, 2024	SELL	$95.53 - $114.62 $1.53 Million - $1.84 Million	-16,057 Reduced 5.77%	262,253 $25.4 Million
Q2 2023 Aug 06, 2024	SELL	$100.78 - $112.29 $31,342 - $34,922	-311 Reduced 0.11%	278,310 $30.3 Million
Q1 2023 Aug 06, 2024	BUY	$96.86 - $114.01 $628,233 - $739,468	6,486 Added 2.38%	278,621 $28.2 Million
Q4 2022 Aug 06, 2024	BUY	$95.06 - $111.52 $51,142 - $59,997	538 Added 0.2%	272,135 $29.9 Million
Q3 2022 Aug 06, 2024	BUY	$96.76 - $112.03 $2.92 Million - $3.38 Million	30,195 Added 12.51%	271,597 $26.3 Million
Q2 2022 Aug 06, 2024	SELL	$102.07 - $123.37 $10.5 Million - $12.7 Million	-102,969 Reduced 29.9%	241,402 $26.2 Million
Q1 2022 Aug 06, 2024	BUY	$114.02 - $139.04 $1.9 Million - $2.32 Million	16,697 Added 5.1%	344,371 $40.8 Million
Q4 2021 Aug 06, 2024	BUY	$115.53 - $141.46 $2.05 Million - $2.51 Million	17,770 Added 5.73%	327,674 $46.1 Million
Q3 2021 Aug 06, 2024	BUY	$116.66 - $129.06 $3.47 Million - $3.84 Million	29,720 Added 10.61%	309,904 $36.6 Million
Q2 2021 Aug 06, 2024	BUY	$105.79 - $124.53 $1.18 Million - $1.39 Million	11,167 Added 4.15%	280,184 $32.5 Million
Q1 2021 Aug 06, 2024	SELL	$108.84 - $128.23 $3.25 Million - $3.83 Million	-29,833 Reduced 9.98%	269,017 $32.2 Million
Q4 2020 Aug 06, 2024	BUY	$105.0 - $114.42 $1.11 Million - $1.21 Million	10,577 Added 4.27%	258,287 $28.3 Million
Q3 2020 Aug 06, 2024	BUY	$91.64 - $111.29 $911,451 - $1.11 Million	9,946 Added 4.18%	247,710 $27 Million
Q2 2020 Aug 06, 2024	BUY	$76.57 - $98.0 $818,456 - $1.05 Million	10,689 Added 4.71%	237,764 $21.7 Million
Q1 2020 Aug 06, 2024	SELL	$62.82 - $91.86 $4.51 Million - $6.59 Million	-71,775 Reduced 24.02%	227,075 $17.9 Million

Others Institutions Holding ABT

# of Institutions

3,370

Shares Held

1.36B

Call Options Held

10.6M

Put Options Held

8.73M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $241B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hantz Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hantz Financial Services, Inc. with notifications on news.

Account

Hantz Financial Services, Inc. Abbott Laboratories Transaction History